Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Aimmune Therapeutics begins Phase II trial of AR101 and dupilumab

A peanut allergy warning sign. Credit: Dan4th Nicholas from Cambridge, MA, USA.

Go Top